Multiscale Metrology Suite for Next-Generation Health Nanotechnologies
Multiscale Metrology Suite for Next-Generation Health Nanotechnologies
批准号:
EP/V028960/1
负责人:
Zahra Rattray
金额:
$108.71万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
定制的多尺度计量套件将结合强大的尖端探测器来测量纳米材料特性,并改变健康纳米技术的测量。我们将建立一个模块化系统,将最新的流场分选技术与质谱、拉曼和光散射探测器相结合,用于纳米材料性质的物理和化学测量。所要求的设备将使斯特拉斯克莱德大学、其他英国学术机构和行业的世界领先研究人员能够加速他们对医疗保健应用新技术的研究,并在提供新的健康创新的全球竞争中保持竞争力。此外,这种设备将产生新的研究途径和合作机会,这将为英国卫生纳米技术研究在物理和化学分析能力和基础设施方面创造一个阶梯式的变化。这一领先的套件将最终减少与提供新的诊断和药物治疗相关的时间和成本,提高生活质量,并为患者提供急需的救命药物。与行业伙伴和政府机构的紧密合作将确保这一国家机构保持全球竞争力并提供创新。
英文摘要
The bespoke Multiscale Metrology Suite, will combine powerful leading-edge detectors for measuring nanomaterial properties and transform the measurement of health nanotechnologies. We will build a modular system combining the latest in flow field fractionation technologies with mass spectrometry, Raman and light scattering detectors for the physical and chemical measurement of nanomaterial properties.The requested equipment will enable world-leading researchers at the University of Strathclyde, other UK academic institutions, and industry to accelerate their research into new technologies for healthcare applications and remain competitive in the global race for delivering new innovations in health. Moreover, this equipment will generate new research avenues and partnership opportunities that will create a step-change in the physical and chemical analytical capability and infrastructure for UK health nanotechnology research. This leading-edge suite will ultimately reduce the time and costs associated with delivering new diagnostics and drug treatments, improving quality of life and delivering much needed lifesaving drugs to patients. Strong partnerships with industry partners and government facilities will ensure that this national facility will remain globally-competitive and deliver innovations.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A roadmap for patient-public involvement and engagement (PPIE): Recounting the untold stories of breast cancer patient experiences
患者与公众参与 (PPIE) 路线图:讲述乳腺癌患者经历中不为人知的故事
DOI:
10.1101/2023.06.19.23291192
发表时间:
2023
期刊:
影响因子:
--
作者:
[Cunningham M]
通讯作者:
Cunningham M
The differential metabolic signature of breast cancer cellular response to olaparib treatment
乳腺癌细胞对奥拉帕尼治疗反应的差异代谢特征
DOI:
10.1101/2022.06.14.495928
发表时间:
2022
期刊:
影响因子:
--
作者:
[Berardi D]
通讯作者:
Berardi D
DOI:
10.1186/s12885-022-09969-4
发表时间:
2022-08-10
期刊:
BMC cancer
影响因子:
3.8
作者:
[]
通讯作者:
Investigating the Impact of Shear Flow on Nanoparticle-Protein Interactions
研究剪切流对纳米颗粒-蛋白质相互作用的影响
DOI:
10.5920/bjpharm.1131
发表时间:
2022
期刊:
British Journal of Pharmacy
影响因子:
--
作者:
[Daramy K]
通讯作者:
Daramy K
Evaluating the impact of experimental shear flow parameters on nanoparticle protein corona formation
评估实验剪切流参数对纳米颗粒蛋白冠形成的影响
DOI:
10.26434/chemrxiv-2023-6bb7b
发表时间:
2023
期刊:
影响因子:
--
作者:
[Daramy K]
通讯作者:
Daramy K
共 9 条
海外基金